| Financial Year |
March 31 2023 |
| Monetary Funds |
70,276,446.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
115,840,566.60 |
| Advances to Suppliers |
21,332,786.92 |
| Other Receivables |
39,481,500.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
985,952.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,231,449.89 |
| Total Current Assets |
284,148,702.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,211,035.32 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
38,996,993.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,570,083.32 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,673.81 |
| R&D expenses |
293,018.36 |
| Goodwill |
28,859,913.59 |
| Long-Term Deferred and Prepaid Expenses |
12,710,464.67 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
241,331.70 |
| Sub-Total of Non-Current Assets |
165,826,057.63 |
| Total Assets |
449,974,759.98 |
| Short-Term Loans |
178,270,477.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
14,025,957.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,292,607.12 |
| Taxes Payable |
12,638,354.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,005,960.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
242,000,976.82 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,318,225.41 |
| Total Liabilities |
270,319,202.23 |
| Paid-In Capital(Or Share Stock) |
504,936,660.00 |
| Capital Surplus |
277,096,356.17 |
| Surplus Reserve |
8,194,929.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-550,909,971.46 |
| Minority Stockholder's Interest |
-3,697,750.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
183,353,307.79 |
| Owner's Equity（Stockholder's Equity） |
179,655,557.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
449,974,759.98 |
